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Abstract
Background: The nonhuman primate (NHP)-related injuries in rabies-enzootic countries is a public health problem of
increasing importance. The aims of this work are to collect data concerning rabies transmission from NHPs to humans; to
collate medical practices regarding rabies postexposure prophylaxis (PEP) in different countries, and to provide an evidence
base to support the decision to apply rabies PEP in this context.
Methodology: To retrieve information, we conducted a literature search from 1960 to January 2013. All reports of rabies in
NHPs and rabies transmission to humans by infected NHPs were included. Also included were studies of travelers seeking
care for rabies PEP in various settings. Data collected by the French National Reference Centre for Rabies concerning NHPs
submitted for rabies diagnosis in France and human rabies exposure to NHPs in travelers returning to France were analyzed
for the periods 1999–2012 and 1994–2011, respectively.
Principal findings: A total of 159 reports of rabies in NHPs have been retrieved from various sources in South America,
Africa, and Asia, including 13 cases in animals imported to Europe and the US. 134 were laboratory confirmed cases. 25
cases of human rabies following NHP-related injuries were reported, including 20 from Brazil. Among more than 2000
international travelers from various settings, the proportion of injuries related to NHP exposures was about 31%. NHPs rank
second, following dogs in most studies and first in studies conducted in travelers returning from Southeast Asia. In France,
15.6% of 1606 travelers seeking PEP for exposure to any animal were injured by monkeys.
Conclusions/significance: Although less frequently reported in published literature than human rabies, confirmed rabies
cases in NHPs occur. The occurrence of documented transmission of rabies from NHPs to human suggests that rabies PEP is
indicated in patients injured by NHPs in rabies-enzootic countries.
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Introduction
Among wildlife, nonhuman primates (NHPs) are known to
harbor a large diversity of zoonotic pathogens and are among the
primary mammals targeted for zoonotic disease surveillance [1].
They are the principal host and sometimes an important
intermediate host of many zoonotic RNA viruses. Among these
viruses, rabies virus, the agent of a lethal encephalitis, is
responsible for around 55,000 human deaths every year [2].
Human rabies is a fatal disease once clinical signs develop. Rabies
postexposure prophylaxis (PEP) consists of thorough wound care,
in combination with rabies vaccine and administration of rabies
immunoglobulin (RIG) if necessary. Despite evidence of rabies
virus spillover in NHPs and of transmission of rabies from NHPs to
humans, neither the World Health Organization (WHO) nor the
United States Centers for Disease Control and Prevention (CDC)
provide specific guidelines regarding rabies PEP following NHP-
related injuries. Guidance emphasizes the role of most frequent
reservoirs and vectors. The recommendation of WHO is to
provide vaccine and RIG in severe, type III injuries (transdermal
bites or scratches, lick on broken skin or mucous membrane, and
contacts with bats) and vaccine only in minor, type II injuries
(minor scratches or abrasions without bleeding) following exposure
from any wild mammal (including implicitly NHPs) in a previously
unvaccinated person [2]). At the international level, PEP
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recommendations after exposure to various animals may differ
across a variety of organizations. This is also the case for
recommendations following exposure to NHPs. The human
animal interactions are too complicated to list every scenario or
most species, given the diversity of mammalian species. Hence, the
US CDC recommends that vaccine and RIG be provided,
regardless of the type of injury, following exposure from any wild
mammal (including implicitly NHPs) for a previously unvaccinated
person exposed to rabies, as evaluated based on risk assessment
[3]. The US Advisory Committee on Immunization Practices and
the National Association of State Public Health Veterinarians deal
with risk assessments and particular taxa, on a case-by-case basis.
Quebec Province (Canada) guidelines recommend the use of
vaccine and RIG following NHP-related injuries [4]. French
guidelines recommend following the WHO guidelines [5]. Cur-
rently, neither the British nor Scottish guidelines recommend the
use of RIG for PEP following NHP-related injuries. The British
guidelines state that ‘‘rabies-infected primates have been sporadi-
cally described in countries where rabies is endemic. Although the
risk of transmission of rabies from a primate bite is extremely low,
these bites occurring in low- or high-risk countries should receive
PEP with vaccine only for a previously unvaccinated subject’’ [6].
The Scottish guidance document, published in 2010, states that all
bites, licks and scratches from NHPs are considered low risk and
therefore ‘‘5 active vaccinations plus no RIG’’ is the suggested PEP
response for a previously unvaccinated person [7].
Therefore, no international consensus has been reached, even
among national recommendations about rabies PEP following a
NHP-related injury. Furthermore, none of the guidelines that we
reviewed are based on published data about rabies in NHPs and
subsequent transmission to humans. To enhance the specificity and
scientific basis of future recommendations and guidelines, we
gathered information on rabies in NHPs and human rabies cases
and exposures following NHP-related injuries. The aims of this work
are to 1) collect and analyze data concerning rabies transmission
from NHPs to humans, 2) collate medical practices regarding rabies
PEP in different countries, and 3) provide an evidence base to
support the decision to apply rabies PEP in this context.
Methods
We searched for all accessible publications and reports
containing relevant information on rabies in NHPs and human
rabies and rabies exposure and PEP following NHP-related
injuries. We also analyzed selected data concerning NHPs
submitted for rabies diagnosis in France and rabies PEP following
NHP-related injuries sustained by French international travelers.
Search strategy
To retrieve information, we conducted a literature search from
1960 to January 2013, using the MEDLINE and SCOPUS
databases, and cross-referenced the following terms: ‘‘rabies,’’
‘‘nonhuman primates,’’ and ‘‘monkey.’’ We also used these same
search terms to conduct a Google search over the same period. We
systematically scanned meeting reports from the Southern and
Eastern African Rabies Group (SEARG). We also scanned the
reference lists and bibliographies of all material identified from
these searches for potentially relevant primary studies that could
be included in the review.
Inclusion criteria
We considered all types of reports in English, French, Spanish,
or Portuguese language, with the exception of NHP experimental
laboratory studies. All reports of rabies in NHPs and rabies
transmission to humans by infected NHPs were included, whether
clinically diagnosed or biologically confirmed. Also included were
studies of travelers seeking care for rabies PEP in various settings.
Analysis of data concerning NHPs submitted for rabies
diagnosis in France and of French national rabies
postexposure prophylaxis data
In France, veterinary and medical doctors collaborate closely to
detect cases and organize the medical responses to rabies. On the
one hand, dogs and cats responsible for human exposure are kept
under veterinary surveillance, when possible. If the animal dies for
any reason, laboratory diagnostics are performed to rule out rabies.
On the other hand, primary health-care management of patients
seeking rabies PEP is delivered through an official national network
of Antirabies Medical Centers distributed throughout the country
[8]. All data collected by veterinarians and medical doctors are
collected and analyzed by the French National Reference Centre
for Rabies (NRCR), at Institut Pasteur in Paris.
Data collected by the NRCR concerning NHPs submitted for
rabies diagnosis in France and human rabies exposure to NHPs in
travelers returning to France were analyzed for the periods 1999–
2012 and 1994–2011, respectively.
Results
South America (Appendix S1, Tables 1 and 2)
Rabies in NHPs is well described in Northeast Brazil in Rio
Grande do Norte, Ceará, Piaui and Pernabucco States, where
rabies cases were documented in marmosets (Appendix S1). These
monkeys are highly adaptable to different habitats and can be
found on plantations and in urban parks. They are also commonly
captured and kept as pets. A new antigenic variant of rabies virus
was identified in marmosets and humans bitten by marmosets,
which strongly suggests, in conjunction with surveillance data, that
these viruses represent a unique, independent rabies endemic cycle
[9]. According to the Brazilian Ministry of Health, over the last
three decades 20 human rabies cases were reported following
marmoset-related injuries in Ceará and Piaui States [9,10]. In
recent years, antibodies against rabies have also been found in
capuchin monkeys in southeastern Brazil in the state of São Paulo
[10], and 2 rabies cases were recorded from the same state in
monkeys for which the species was not documented, according to
the Pan American Health Organization (PAHO) epidemiological
Author Summary
No international consensus or even a consensus among
existing national recommendations about rabies postex-
posure prophylaxis (PEP) following a nonhuman primate
(NHP)-related injury currently exists. Epidemiologic studies
and reports collated in this review indicate that the
number of rabies case reported in NHPs are rare compared
with humans. This finding might be because of a lower
contact rate of NHPs with rabid reservoir but also very
likely because of underreporting. Nevertheless, document-
ed cases and subsequent transmission to humans have
been reported from various sources in South America,
Africa, and Asia. Further, international travelers often
report NHP-related injuries and NHPs can be close to
humans. Little is currently known of the pathobiology of
rabies virus shedding in primates, which implies that rabies
PEP and administration of rabies immunoglobulin should
be considered in patients with a possible exposure.
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information system. Finally, 4 rabies cases were reported in
monkeys (species not available) from Mato Grosso in 2010–2011
according to PAHO. In Peru, rabies cases were suspected in
humans following pet monkey bites (species not available) from
1999 to 2006 in the region of Lima, although monkeys tested
positive by serology, further laboratory investigations led to the
conclusion of false positive [11]. Three rabies cases were
documented in squirrel monkeys imported from Peru to the
United States in the early 1960s [12], as well as one in a marmoset
where infection was very likely vaccine-induced [13].
Rabies cases were reported sporadically in monkeys in Argentina,
Bolivia, Colombia, Cuba, Ecuador, and Paraguay, according to
PAHO. One case was documented in a ringtail monkey imported
from Colombia to the United States in 1947 [12].
It must be pointed-out that no information is provided about the
diagnostic criteria that were used for cases reported by PAHO.
Africa (Appendix S1, Table 2)
Data published in the medical literature about rabies in African
NHPs are scant [14–18]. Meeting reports of the SEARG (web site:
Table 1. Human rabies1 cases following nonhuman primate-related injuries.
Country of exposure Year Animal number of human cases References
America
Brazil (States of Ceará and Piauis)1 1980–2008 Marmoset 20 9,10
Asia
India (Australian traveler)2 1988 Monkey5 1 24
India3 1998 Monkey5 1 20
India3 1999 Monkey5 1 23
India (German traveler)4 2004 Monkey5 (NB/had also contacts with dogs) 1 25
Sri Lanka3 1975 Monkey5 1 22
1confirmed by molecular analysis.
2confirmed by histological observation of Negri bodies in the brain.
3rabies diagnosis was assessed on clinical criteria only.
4confirmed by fluorescent antibody testing of brain samples, molecular analysis and mouse inoculation with brain material.
5species not stated.
doi:10.1371/journal.pntd.0002863.t001
Table 2. Confirmed rabies in imported nonhuman primates.
Country of importation Year Animal (number of cases) Country of origin Reference
US1 1929 Monkey6 Not stated 12
US1 1936 Monkey6 Not stated 12
US1,2 1947 Ringtail (Cebus spp.) Colombia 12
US1,2 1955 Cynomolgus (Macacca fasicularis) Philippines 12
US2,3 1961 Squirrel monkey (Siamiri sciureus) Peru 12
US1,2,3 1963 Squirrel monkey (Siamiri sciureus Peru 12
US1,2,3 1963 Squirrel monkey (Siamiri sciureus Peru 12
UK1,2 1965 Rhesus (Macaca mulatta) India 21
US2,3 1972 Capuchin monkey Not stated Center for Disease Control, 1972 (internal report)
US2,3 1972 Chimpanzee Sierra Leone 19
US2,3 1974 Marmoset (Saguinus nigricollis) Peru Center for Disease Control, 1976 (internal
report), 13
France4 1989 Common macaque (Macaca sylvana) Morocco National Reference Center for Rabies- France
1989 (unpublished report)
France5 1989 Common macaque (Macaca sylvana) Morocco National Reference Center for Rabies- France
1989 (unpublished report)
1confirmed by histological observation of Negri bodies in the brain.
2confirmed by mouse inoculation with brain material.
3confirmed by fluorescent antibody testing of brain samples.
4This monkey had been vaccinated with a modified live-virus rabies vaccine of avian origin, 13 days before the onset of symptoms. The viral isolate from the rabid
monkey had characteristics consistent with an egg-adapted vaccine strain suggesting that the monkey’s infection was vaccine-induced. These included a short
incubation period in mice (4–5 days), absence of fluorescent rabies antibodies detectable virus in salivary glands and corneas of the mice, only rare inclusions typical of
Negri bodies produced on mouse passage, and high titered growth in eggs on first passage.
5These monkeys had been vaccinated with a modified live-virus rabies vaccine (strain ERA) 43 and 28 days before the onset of the symptoms, suggesting that the
monkey’s infection was vaccine induced, although sequencing or typing were not done.
6species not stated.
doi:10.1371/journal.pntd.0002863.t002
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http://searg.info/doku.php?id = start) provide some evidence of
rabies in NHPs in a number of African countries, including
Ethiopia, Ghana, Kenya, Madagascar, Malawi, Mozambique,
Namibia, Sudan, Uganda, and Zambia (Appendix S1). The
species of primate in these reports is rarely documented. However,
cases were reported in baboons, a gorilla, a bush baby, a vervet
monkey, and lemurs. One case was reported in a chimpanzee
imported from Sierra Leone to the United States in 1972 [19]. In
France, 61 NHPs suspected of rabies were submitted for diagnosis
to the NRCR, at Institut Pasteur, from 1999 to December 2012.
Nine (14.5%) of these animals were sent directly from rabies-
enzootic African countries to the NRCR for diagnosis or illegally
imported from Africa to France and submitted for rabies diagnosis
by the French veterinary services. None were found positive. The
last two positive cases were in two common macaques (Macaca
sylvana) vaccinated with a modified live-virus rabies vaccine (strain
ERA) 43 and 28 days before the onset of the symptoms, suggesting
that the monkey’s infection was vaccine-induced. More than 50
people were exposed to these monkeys and received rabies
PEP. Despite intensive searches, we were unable to find a
documented human rabies case following exposure from an
African NHP.
Asia and the Middle East (Appendix S1, Tables 1 and 2)
Few published results about rabies in NHPs in Asia are
available. Unfortunately, country reports about animal rabies in
Asia that can be found in reports of symposium on rabies control
in Asia co-organized by the Mérieux Foundation and the WHO
do not address NHPs specifically. Rabies cases were reported in
monkeys, langurs, and baboons in India [20], including one case
in a macaque imported to London in 1965 for laboratory
experiments [21]. One case was reported in a macaque imported
from the Philippines to the United States in 1955 [12]. Rare
human rabies cases following monkey bites have been reported in
local populations in India and Sri Lanka, based on clinical
diagnosis [20,22,23] and in two travelers returning from India to
Australia and Germany, based on histopathology in the first case
and direct immunofluorescence and virus isolation in the second
case [24,25]. One case was documented in a pet monkey in Jordan
[26]. In France, only one NHP imported from Indonesia was
submitted for rabies diagnosis to the NRCR from 1999 to
December 2012, and it was found negative.
NHP-related injuries requiring rabies PEP in travelers
(Table 3)
A number of studies were conducted in travelers seeking care for
rabies PEP in various settings [27–40]. Data are available from
more than 2000 people, and the proportion of injuries related to
NHP exposures is about 31%, with the smallest proportion
observed in US military personnel stationed in Afghanistan (8%)
and the largest reported from travelers returning from Bali,
Indonesia, at various GeoSentinel clinics (69%). Overall, dogs are
usually the most frequently reported species responsible for injuries
requiring rabies PEP in travelers. However, NHPs rank second in
most studies and first in studies conducted in travelers returning
from Southeast Asia (34,35,37,40). In France, data are available
from 1606 travelers exposed to NHPs from 1994 to 2011,
representing 1.7% of the total number of people and 15.6% of
travelers seeking PEP in France for exposure to any animal, during
the same period. The number of travelers exposed to NHPs and
receiving PEP in France has increased since 2002, especially in
2004 and 2005 (Figure 1) because of a strong demand for
antirabies prophylaxis following a well-publicized rabies case in a
dog imported to France in 2004 [8]. This proportion increased to
3.1% by 2008–2011 (Figure 1), further indicating that the NHP
related injuries in rabies-enzootic countries is a public health
problem of increasing importance. The largest proportion of
travelers exposed to NHPs and receiving PEP in France during the
period 1994–2012 had returned from Asia and the Middle East
(53.3%), followed by Africa (36.9%) and the Americas (5%). In
Asia and the Middle East, the most frequent country of exposure
was Thailand (22.4% of the treated patients).
Discussion
We retrieved a total of 134 confirmed cases of rabies in NHPs
which have been reported from various sources in South America,
Africa, and Asia, including 13 cases in animals imported to
Europe and the US. We retrieved 25 cases of rabies transmission
to humans following NHP-related injuries, 20 of which occurred
in Brazil. Rabies cases in NHP from Brazil were confirmed
by genetic analysis [9]. Additionally 4 capuchin monkeys were
found with positive serology in southeastern Brazil [10]. By
contrast, 21 NHPs from other regions in Latin America were
reported rabid by the PAHO with no information about the
methods used for the assessment of rabies. It is therefore possible
that these so-called ‘‘cases’’ were actually healthy animals with a
positive-serology. Such so-called ‘‘cases’’ reported in Peru, finally
turned out not to be rabies [11]. We cannot exclude that rabies
cases reported in NHPs from São Paulo and Mato Grosso in
Brazil and from other countries in South America by the PAHO
could be actually healthy animals with positive serology. There
are issues with the PAHO data that may contain inaccuracies and
should not be considered the gold standard. Imported cases from
Peru and Colombia, however were confirmed by fluorescent
rabies antibody examination of brain tissue, demonstration of
negri bodies on microscopic examination or rabies induced in
mice inoculated with brain tissue [12,13]. Cases reported in wild
NHPs in various countries in Africa by the SEARG (Appendix
S1) and other authors [14–18], in India [20] and Jordan [26], as
well as in the imported cases from Sierra Leone [19] India [21]
and the Philippines [12] were all confirmed by brain tissue
histology, fluorescent antibody testing of brain tissue and mouse
inoculation.
The reports collated in this study support the view that
confirmed rabies cases in NHPs are rarely reported compared
with human rabies cases. In light of numerous biological
reports establishing the susceptibility of NHPs to rabies, we might
have expected the number of NHPs with rabies to have been
greater than observed. Several explanations for this finding are
possible.
First, with the possible exception of the cluster of marmosets in
Ceará State, Brazil (9), NHPs are not known to be a reservoir for
maintaining a rabies virus variant in the wild. Second, given that
dogs are a domesticated species, sharing a closer bond and degree
of interaction with humans than do NHPs, the difference in the
contact rates with dogs may account, in part, for the difference in
reported rates of rabies between humans and NHPs. However,
NHPs are frequently kept as pets and can be close to humans in
some regions. Finally, underreporting of rabies in NHPs is likely to
be significant. The passive nature of rabies surveillance likely
accounts for underreporting of rabid NHPs. Rules pertaining to
the submission of animal specimens for rabies diagnosis and
reporting to national authorities are sometimes weak and may only
cover the few species considered to be economically important or
those most important in terms of public health. Last, rabies cases
in NHPs are not notifiable in many countries and as such are not
recorded in official statistics.
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Underreporting of rabies in NHPs is a major impediment to
understanding the epidemiology of this disease and may hinder the
development of control strategies. We show that a review of
published reports can be an important way to overcome the
problem of underreporting and can contribute to the advancement
of the understanding of the importance of rabies in NHPs as a
potential hazard to humans. Moreover, valuable information exists
in internal reports, which is not easily available since it is not
indexed in MEDLINE and SCOPUS databases.
More complete and precise information pertaining to rabies in
NHPs is needed. This information could be obtained through field
surveys. We believe a greater effort should be directed toward
coordinating and frequently reviewing the need for rabies PEP
after exposure to animal species such as NHPs that are not
primary reservoirs of rabies. Information obtained in this way
should be regularly collected, updated, and made available to the
medical community. To this end, efforts towards greater openness
and accessibility of information regarding the incidence of rabies
in NHPs and its geographic distribution would provide a much-
needed basis for improving and sustaining the public health debate
around the risk evaluation of rabies after human exposure to these
species.
To address the possibility of reintroduction of rabies through
NHPs, countries that are designated as rabies-free should strongly
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consider permitting their entry only under license. Live animal
importations to such countries would benefit from quarantine
guideline under conditions approved by governmental veterinary
services.
We show that, although rarely reported, documented cases of
rabies infections in NHPs and subsequent transmission to humans
do occur. Little is currently known about the pathobiology of
rabies virus shedding in primates. The occurrence of documented
transmission of rabies from NHPs to human suggests that rabies
PEP is indicated in patients injured by NHPs in rabies-enzootic
countries. We were unable to find any report suggesting failure or
death in previously unvaccinated persons who received vaccine
without RIG after exposure to NHP, however, rabies status of
NHP was not documented in these reports. From a clinical
perspective, distinct recommendations are found depending on
national guidelines. United Kingdom guideline state that the risk
of rabies following NHP-related injury is extremely low and that
rabies PEP with vaccine only should be applied in previously
unvaccinated people [6,7]. A contrario, WHO, the US CDC,
Canadian and French guideline state that the catastrophic nature
of the disease with a nearly 100% mortality rate is what will drive
treatment, not the low probability of the disease and that rabies
vaccine and RIG should be applied in previously unvaccinated
people [2–5]. As long as wild life studies addressing the role NHPs
play in the disease transmission to humans are not available from
various area where human exposure occur and as recommended
by WHO, we consider that a precautionary principle should be
applied and that RIG should be administered, as with any other
animal exposures, despite the large number of doses that would be
necessary, even in the setting of a RIG shortage.
Based on our review of published reports, a large number of
international travelers sustain NHP-related injuries during their
trips. Information about the risks posed by exposure to NHPs in
enzootic countries, especially in India and Southeast Asia, should
be disseminated to the traveling public to help minimize these
injuries and the subsequent need for rabies PEP. Travelers should
be encouraged to seek a pretravel medical consultation from their
health-care provider 4–6 weeks before travel to discuss if rabies
pre-exposure vaccination may be recommended in situations
where travel activities may involve a higher potential for
contact with animals such as NHPs. Travelers should also be
encouraged to seek immediate medical care if injured by an NHP
species.
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